Watch VMD. Know when insiders buy.
One email the day a filing lands. Free.
VMD
VIEMED HEALTHCARE, INC.
9.13
+0.05 +0.55%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $347.7MP/E 25.4DIV YIELD —FCF YIELD 8.41%REV TTM $301.6M +25.2%NET INCOME $14.5M +3.7%NET CASH $3.6M52W 6.26 – 12.33SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $78.1M | +23.9% | 57.7% | $4.5M | $2.8M | −12.4% | 0.07 | $15.9M | $8.5M | $7.4M | Aug 3 |
| Q1 2026 · Mar 31 | $75.4M | +27.5% | 56.8% | $4.3M | $2.6M | −1.6% | 0.06 | $8.1M | $6.7M | $1.4M | May 5 |
| Q4 2025 · Dec 31derived | $76.2M | +25.5% | 57.9% | $8.4M | $5.6M | +30.7% | 0.14 | $18.4M | $8.7M | $9.7M | Mar 4 |
| Q3 2025 · Sep 30 | $71.9M | +24.0% | 57.5% | $5.6M | $3.5M | −9.4% | 0.09 | $18.4M | $7.6M | $10.7M | Nov 5 |
| Q2 2025 · Jun 30 | $63.1M | +14.7% | 58.3% | $5.1M | $3.2M | +115.1% | 0.08 | $12.3M | $8.1M | $4.1M | Aug 3 |
| Q1 2025 · Mar 31 | $59.1M | +16.9% | 56.3% | $3.8M | $2.6M | +63.8% | 0.06 | $2.9M | $15.5M | −$12.6M | May 5 |
| Q4 2024 · Dec 31derived | $60.7M | +19.6% | 59.5% | $6.5M | $4.3M | +24.1% | 0.11 | $15M | $11.8M | $3.2M | Mar 4 |
| Q3 2024 · Sep 30 | $58M | +17.4% | 59.3% | $5.6M | $3.9M | +32.9% | 0.10 | $12.7M | $11M | $1.7M | Nov 5 |
| Q2 2024 · Jun 30 | $55M | — | 59.8% | $3.6M | $1.5M | — | 0.04 | $10.2M | $8.9M | $1.2M | Aug 6 |
| Q1 2024 · Mar 31 | $50.6M | — | 58.9% | $2.2M | $1.6M | — | 0.04 | $1.2M | $6M | −$4.8M | May 7 |
| Q4 2023 · Dec 31derived | $50.7M | — | 63.3% | $5.3M | $3.5M | — | 0.08 | $13.3M | $7.9M | $5.4M | Mar 4 |
| Q3 2023 · Sep 30 | $49.4M | — | 61.9% | $4.2M | $2.9M | — | 0.07 | $13.8M | $7.4M | $6.4M | Nov 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $270.3M | 57.5% | $22.9M | $14.9M | 5.5% | 0.37 | $51.9M | $40M | $11.9M | $13.2M | — |
| FY2024 · to Dec 31 | $224.3M | 59.4% | $17.9M | $11.3M | 5.0% | 0.28 | $39.1M | $37.8M | $1.3M | $0 | — |
| FY2023 · to Dec 31 | $183M | 61.6% | $14.3M | $10.2M | 5.6% | 0.25 | $45.2M | $26.1M | $19.1M | $0 | — |
| FY2022 · to Dec 31 | $138.8M | 61.0% | $8.3M | $6.2M | 4.5% | 0.16 | $27.7M | $22.9M | $4.8M | $9.6M | — |
| FY2021 · to Dec 31 | $117.1M | 62.7% | $11.6M | $9.1M | 7.8% | 0.22 | $22.5M | $19.7M | $2.8M | $0 | — |
| FY2020 · to Dec 31 | $131.3M | 61.0% | $26.8M | $31.5M | 24.0% | 0.78 | $35.1M | $13M | $22.1M | $0 | — |
Every number comes from VIEMED HEALTHCARE, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.